BeyondSpring Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in BeyondSpring Pharmaceuticals?

BeyondSpring Pharmaceuticals has 2 investors including Fang Fund Partners And Xintong Capital.

Q: How much funding has BeyondSpring Pharmaceuticals raised to date?

BeyondSpring Pharmaceuticals has raised obfuscated.

Overview

BeyondSpring Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About BeyondSpring Pharmaceuticals

CB Rank

79298

Spring Pharmaceuticals is a biotechnology company based in Duncan, South Carolina.

Founded

obfuscation

Public

Series A

New York, New York, United States

11-50

beyondspringpharma.com/

Biopharma

Health Care

Manufacturing

Pharmaceutical

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Lan Huang: CEO & Co-Founder
Elizabeth Adkins Czerepak: Chief Financial Officer
Past Role: Altimmune, Chief Financial Officer & Executive Vice President of Corporate Development

Details

Legal Name

BeyondSpring, Inc.

Also Known As

BeyondSpring

Operating Status

Active

Stock Symbol

NASDAQ:BYSI

Company Type

For Profit

Founders

Lan Huang

About the Company

Spring Pharmaceuticals is a biotechnology company based in Duncan, South Carolina.

Phone Number

+1-646-305-6387

Contact Email

general@beyondspringpharma.com

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Insight

See this Growth Insight

BeyondSpring Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Growth Prediction

See this Growth Prediction

Products & Services

Plinabulin

Plinabulin is an intravenous small molecule drug developed for cancer treatment and prevention of chemotherapy-induced neutropenia (CIN).

BPI-002

BPI-002 is an orally administered small molecule agent targeting viral infections, including COVID-19, by stimulating T-cell immune responses.

Research & Development

BeyondSpring Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - BeyondSpring Pharmaceuticals	2	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Fang Fund Partners	—	Series A - BeyondSpring Pharmaceuticals	—
Fang Fund Partners	—	Series A - BeyondSpring Pharmaceuticals	—
Fang Fund Partners	—	Series A - BeyondSpring Pharmaceuticals	—
Fang Fund Partners	—	Series A - BeyondSpring Pharmaceuticals	—
Fang Fund Partners	—	Series A - BeyondSpring Pharmaceuticals	—